Skip to content

8-KAccepted Nov 16, 7:00 AM ET

Instil Bio, Inc.: reports results for quarter ended Sep 30, 2026

TILInstil Bio, Inc.

Accepted (ET)

7:00 AM

Nov 16, 2026

Filed

Nov 16, 2026

Documents

13

Size

256.0 KB

Summary

Instil Bio, Inc.: reports results for quarter ended Sep 30, 2026

Updated

What happened Instil Bio, Inc. announced that on Nov 16, 2026 it provided a corporate update and announced its financial results for the quarter ended Sep 30, 2026. The announcement was made in a press release dated Nov 16, 2026 that the company attached as Exhibit 99.1 to the Form 8-K.

Key details

  • The event was reported under Item 2.02: Results of operations and financial condition.
  • The press release is dated Nov 16, 2026 and covers the quarter ended Sep 30, 2026.
  • The Form 8-K was signed by Sandeep Laumas, M.D., Chief Financial Officer and Chief Business Officer, on Nov 16, 2026.
  • The press release is filed as Exhibit 99.1 to the Form 8-K.

Why it may matter Item 2.02 reports results of operations and financial condition, which covers the company’s reported financial performance for the stated quarter as disclosed in the attached press release. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing